Source: BioPortfolio

Oxford BioTherapeutics: Oxford BioTherapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 11072018 Prices from USD $250

SummaryOxford BioTherapeutics Ltd OBT is a clinical stage oncology company that develops antibody drug conjugates for the treatment of variety of cancers. The company's product pipelines currently includes Tcell based IO therapies including check point mod...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Christian Rohlff's photo - Founder & CEO of OBT

Founder & CEO

Christian Rohlff

CEO Approval Rating

86/100

OBT is a biotechnology company that focuses on the discovery and development of therapeutics for the treatment of cancer. Read more